{"id":52801,"date":"2023-01-11T15:02:16","date_gmt":"2023-01-11T14:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/"},"modified":"2023-01-11T15:02:16","modified_gmt":"2023-01-11T14:02:16","slug":"ice-global-consulting-inc-completes-acquisition-of-epicenter-technology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/","title":{"rendered":"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology"},"content":{"rendered":"
\n

RALEIGH, N.C.–(BUSINESS WIRE)–ICE Global Consulting, Inc. (ICE Global) announced today that it has entered into an asset purchase agreement to acquire all operating assets related to the Epicenter\u2122 contracts management technology from Journey CTS, LLC. ICE Global\u2019s most recent acquisition further solidifies its technology-driven approach to supporting global site contracting, investigator budgeting, and site payments in the clinical research industry.\n<\/p>\n

\nICE Global\u2019s CEO, Brooke Millman-Ice, stated, \u201cEpicenter\u2122 is the first of its kind, purpose-built technology specifically targeting operational administration of global site contracts and investigator budgets. Until now, organizations have been forced to rely on commercially available technology options that support processing of client and vendor contracts but are inadequate for efficient site contracts management.\u201d\n<\/p>\n

\nEpicenter\u2019s core strengths center around its three primary functions \u2013 as a negotiation workflow management tool utilized by global negotiation teams, as an organizational repository for storage and access to executed agreements for its Contract Research Organization (CRO) and pharmaceutical clients, and as a portal to supply real-time data and transparency into the overall progress of program and study-level site negotiations.\n<\/p>\n

\n\u201cClients have access to data, analytics, and negotiation details through the Epicenter\u2122 platform. The data and transparency of a tech-enabled process allows our team of lawyers to recommend strategic and tactical solutions to our clients throughout study start-up,\u201d says Phil Lemons, ICE Global\u2019s Chief Business Officer.\n<\/p>\n

\nLooking Ahead<\/b>\n<\/p>\n

\nICE Global continues to collaborate with its clients and team of developers to create the next generation of Epicenter\u2019s capabilities. \u201cTo be optimally effective partners to our clients, we will continue to focus on the current and future technology needs within clinical research to better support study start-up activities,\u201d said Millman-Ice.\n<\/p>\n

\nNo financial details of the transaction were disclosed.\n<\/p>\n

\nAbout ICE Global Consulting, Inc.<\/b>\n<\/p>\n

\nICE Global Consulting, Inc. is a clinical research consulting company focused on decreasing the administrative hurdles associated with site contract and budget negotiation, site payments and staffing. Through its team of dedicated attorneys and experienced global negotiators, ICE Global delivers timely and high-quality clinical contracts and budgets, allowing its pharmaceutical and CRO clients to safely turn their attention to other critical areas of study start-up. Our experienced site payments team utilizes state-of-the-art technology and provides superior customer support to eliminate frustrations often communicated by sites.\n<\/p>\n

\nFor more information on ICE Global Consulting, Inc., visit https:\/\/iceglobalconsulting.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nICE Global Consulting, Inc.
\n
Phil Lemons, CBO
\n
+1 919.610.0253
\n
plemons@iceglobalconsulting.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RALEIGH, N.C.–(BUSINESS WIRE)–ICE Global Consulting, Inc. (ICE Global) announced today that it has entered into an asset purchase agreement to acquire all operating assets related to the Epicenter\u2122 contracts management technology from Journey CTS, LLC. ICE Global\u2019s most recent acquisition further solidifies its technology-driven approach to supporting global site contracting, investigator budgeting, and site payments … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52801","6":"format-standard","7":"category-industry"},"yoast_head":"\nICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RALEIGH, N.C.–(BUSINESS WIRE)–ICE Global Consulting, Inc. (ICE Global) announced today that it has entered into an asset purchase agreement to acquire all operating assets related to the Epicenter\u2122 contracts management technology from Journey CTS, LLC. ICE Global\u2019s most recent acquisition further solidifies its technology-driven approach to supporting global site contracting, investigator budgeting, and site payments ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-11T14:02:16+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology\",\"datePublished\":\"2023-01-11T14:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/\",\"name\":\"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-01-11T14:02:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/","og_locale":"en_US","og_type":"article","og_title":"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology - Pharma Trend","og_description":"RALEIGH, N.C.–(BUSINESS WIRE)–ICE Global Consulting, Inc. (ICE Global) announced today that it has entered into an asset purchase agreement to acquire all operating assets related to the Epicenter\u2122 contracts management technology from Journey CTS, LLC. ICE Global\u2019s most recent acquisition further solidifies its technology-driven approach to supporting global site contracting, investigator budgeting, and site payments ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-11T14:02:16+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology","datePublished":"2023-01-11T14:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/"},"wordCount":413,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/","url":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/","name":"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-01-11T14:02:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ice-global-consulting-inc-completes-acquisition-of-epicenter-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ICE Global Consulting, Inc. Completes Acquisition of Epicenter\u2122 Technology"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52801"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52801\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}